CANCER AND METASTASIS REVIEWS

期刊基本信息

  • 期刊名称:CANCER AND METASTASIS REVIEWS
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:0167-7659
  • 期刊EISSN:1573-7233
  • 简称:CANCER METAST REV
  • 影响因子:8.7
  • 实时影响因子:截止2025年5月19日:8.757
  • 五年影响因子:10.1
  • JCI期刊引文指标:1.18
  • h-index:134
  • 2024-2025自引率:0.00%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/canc
  • 是否OA开放访问:No
  • 出版商:Springer US
  • 出版年份:1982

CANCER AND METASTASIS REVIEWS

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.

Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.

A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

  • 通讯方式:SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
  • 涉及的研究方向:医学-肿瘤学
  • 出版国家或地区:UNITED STATES
  • 出版语言:English
  • 年文章数:54
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-7659%5BISSN%5D
  • 平均录用比例:较难

CITESCORE

CiteScoreSJRSNIPCiteScore排名
14.002.5961.582
学科分区排名百分位
大类:Medicine
小类:Oncology
Q137 / 415
91%
大类:Medicine
小类:Cancer Research
Q129 / 233
87%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ134/326
89.7%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ162/326
81.13%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区4区
ONCOLOGY
肿瘤学
4区4区2区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 3区2区4区
ONCOLOGY
肿瘤学
2区3区2区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友